Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review - CBC.ca

The Phase II trial in Toronto, sponsored by a charity called the Remedy Institute, was issued a non-compliant rating on June 22, according to Health Canada. It's one of two active trials in the country.

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. The Phase II… [+4961 chars]

full article...